KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Receivables - Net: 2018-2025

Historic Receivables - Net for Twist Bioscience (TWST) over the last 7 years, with Sep 2025 value amounting to $57.0 million.

  • Twist Bioscience's Receivables - Net rose 63.36% to $57.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.0 million, marking a year-over-year increase of 63.36%. This contributed to the annual value of $57.0 million for FY2025, which is 63.36% up from last year.
  • Twist Bioscience's Receivables - Net amounted to $57.0 million in FY2025, which was up 63.36% from $34.9 million recorded in FY2024.
  • Twist Bioscience's 5-year Receivables - Net high stood at $57.0 million for FY2025, and its period low was $34.9 million during FY2024.
  • Moreover, its 3-year median value for Receivables - Net was $44.1 million (2023), whereas its average is $45.3 million.
  • Its Receivables - Net has fluctuated over the past 5 years, first declined by 20.79% in 2024, then soared by 63.36% in 2025.
  • Yearly analysis of 4 years shows Twist Bioscience's Receivables - Net stood at $40.3 million in 2022, then grew by 9.36% to $44.1 million in 2023, then declined by 20.79% to $34.9 million in 2024, then skyrocketed by 63.36% to $57.0 million in 2025.